110 related articles for article (PubMed ID: 10887892)
1. Cardiac effects of contrast media in MR angiography: evaluation in an experimental model of myocardial ischemia.
Castano M; Cipolla P; Garribba D; Tirone P
Acad Radiol; 1999 Dec; 6(12):719-22. PubMed ID: 10887892
[TBL] [Abstract][Full Text] [Related]
2. Acute cardiotoxicity of gadolinium-based contrast media: findings in the isolated rat heart.
Akre BT; Dunkel JA; Hustvedt SO; Refsum H
Acad Radiol; 1997 Apr; 4(4):283-91. PubMed ID: 9110026
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxicity of iodinated and gadolinium-based contrast agents in renal tubular cells at angiographic concentrations: in vitro study.
Heinrich MC; Kuhlmann MK; Kohlbacher S; Scheer M; Grgic A; Heckmann MB; Uder M
Radiology; 2007 Feb; 242(2):425-34. PubMed ID: 17179401
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular responses after ionic and nonionic magnetic resonance contrast media in rats with acute myocardial infarction.
Li HT; Saeed M; Wendland MF; Higgins CB
Invest Radiol; 1993 Jan; 28(1):11-9. PubMed ID: 8425847
[TBL] [Abstract][Full Text] [Related]
5. An experimental study on the neurotolerability of gadobenate dimeglumine in a rat model of focal brain ischemia.
La Noce A; Miragoli L; Samuelli G; Tirone P
Invest Radiol; 1996 Sep; 31(9):550-5. PubMed ID: 8877491
[TBL] [Abstract][Full Text] [Related]
6. Neurotolerability of contrast agents in rats with brain ischemia induced by transient middle cerebral artery occlusion: EEG evaluation.
Frigeni V; Miragoli L; Grotti A; Lorusso V
Invest Radiol; 2001 Jan; 36(1):1-8. PubMed ID: 11176255
[TBL] [Abstract][Full Text] [Related]
7. Comparative study between gadobenate dimeglumine and gadobutrol in rats with brain ischemia: evaluation of somatosensory evoked potentials.
Frigeni V; Miragoli L; Grotti And A; Lorusso V
Invest Radiol; 2001 Oct; 36(10):561-72. PubMed ID: 11577266
[TBL] [Abstract][Full Text] [Related]
8. Acute hemodynamic effects of recently developed monomer and dimer magnetic resonance imaging contrast media: a comparative study.
Geschwind JF; Saeed M; Wendland MF; Szolar D; Derugin N; Higgins CB
Acad Radiol; 1996 Aug; 3(8):667-77. PubMed ID: 8796731
[TBL] [Abstract][Full Text] [Related]
9. Multislice measurement of first-pass transit of gadobenate dimeglumine in normal and ischemic myocardium in dogs.
Sakuma H; Wendland MF; Saeed M; Derugin N; Geschwind JF; Lauerna K; Mintorovitch J; Cavagna FM; Higgins CB
Acad Radiol; 1995 Oct; 2(10):864-70. PubMed ID: 9419652
[TBL] [Abstract][Full Text] [Related]
10. General pharmacology in experimental animals of gadobenate dimeglumine (MultiHance), a new magnetic resonance imaging contrast agent.
Tirone P; Castano M; Cipolla P; Frigeni V; La Noce A; Luzzani F; Valenti R; de Haën C
J Comput Assist Tomogr; 1999 Nov; 23 Suppl 1():S195-206. PubMed ID: 10608415
[TBL] [Abstract][Full Text] [Related]
11. Neurotolerability of gadobenate dimeglumine in a rat model of focal brain ischemia: EEG evaluation.
La Noce A; Frigeni V; Demicheli F; Miragoli L; Tirone P
Invest Radiol; 1999 Apr; 34(4):262-7. PubMed ID: 10196717
[TBL] [Abstract][Full Text] [Related]
12. [Mutagenicity study of gadobenate dimeglumine formulation (E7155) (3)--Micronucleus test in rat bone marrow cells].
Toritsuka N; Daimon H; Sawada S; Sagami F; Tirone P; Morisetti A; Bussi S; Fassio F
J Toxicol Sci; 1999 Nov; 24 Suppl 1():103-6. PubMed ID: 10637785
[TBL] [Abstract][Full Text] [Related]
13. Comparison of cardiovascular changes after administration of gadodiamide injection and gadopentetate dimeglumine in dogs.
Bøkenes J; Hustvedt SO; Refsum H
Acad Radiol; 1997 Mar; 4(3):204-9. PubMed ID: 9084778
[TBL] [Abstract][Full Text] [Related]
14. Low dose gadobenate dimeglumine for imaging of chronic myocardial infarction in comparison with standard dose gadopentetate dimeglumine.
Bauner KU; Reiser MF; Huber AM
Invest Radiol; 2009 Feb; 44(2):95-104. PubMed ID: 19077911
[TBL] [Abstract][Full Text] [Related]
15. Combined blood pool and extracellular contrast agents for pediatric and young adult cardiovascular magnetic resonance imaging.
Johnson JT; Robinson JD; Deng J; Rigsby CK
Pediatr Radiol; 2016 Dec; 46(13):1822-1830. PubMed ID: 27576457
[TBL] [Abstract][Full Text] [Related]
16. Toxicological safety evaluation of gadobenate dimeglumine 0.5 M solution for injection (MultiHance), a new magnetic resonance imaging contrast medium.
Morisetti A; Bussi S; Tirone P; de Haën C
J Comput Assist Tomogr; 1999 Nov; 23 Suppl 1():S207-17. PubMed ID: 10608416
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Low-Dose Higher-Relaxivity and Standard-Dose Lower-Relaxivity Contrast Media for Delayed-Enhancement MRI: A Blinded Randomized Crossover Study.
Cheong BY; Duran C; Preventza OA; Muthupillai R
AJR Am J Roentgenol; 2015 Sep; 205(3):533-9. PubMed ID: 26295638
[TBL] [Abstract][Full Text] [Related]
18. Gadobenate dimeglumine (MultiHance) in MR angiography: an in-vitro phantom comparison with gadopentetate dimeglumine (Magnevist) at different concentrations.
Johansson L; Kirchin MA; Ahlström H
Acta Radiol; 2012 Dec; 53(10):1112-7. PubMed ID: 23081961
[TBL] [Abstract][Full Text] [Related]
19. Assessment of nonischemic fibrosis in hypertrophic cardiomyopathy: comparison of gadopentetate dimeglumine and gadobenate dimeglumine for enhanced cardiovascular magnetic resonance imaging.
Rudolph A; von Knobelsdorff-Brenkenhoff F; Wassmuth R; Prothmann M; Utz W; Schulz-Menger J
J Magn Reson Imaging; 2014 May; 39(5):1153-60. PubMed ID: 24151119
[TBL] [Abstract][Full Text] [Related]
20. Contrast-enhanced MR Angiography of the renal arteries: blinded multicenter crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine.
Prokop M; Schneider G; Vanzulli A; Goyen M; Ruehm SG; Douek P; Daprà M; Pirovano G; Kirchin MA; Spinazzi A
Radiology; 2005 Feb; 234(2):399-408. PubMed ID: 15616119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
